Cardiovascular Applications of Fluorocarbons in Regional Ischemia/Reperfusion

References

• Oesterle S, Eisenhauer A C. Interventional Cardiology. The Guide to Cardiology 2nd edition, RA Kloner. LeJacq Communications, New York 1990; 241–259
   Google Scholar
• Turi Z G, Rezkalla S, Campbell C A, Kloner R A. Amelioration of ischemia during angioplasty of the left anterior descending coronary artery with an autoperfusion catheter. Am. J. Cardiol 1988; 62: 513–517
   PubMedGoogle Scholar
• Roberts C S, Anderson H V, Carboni A A, Justicz A GS, Leimgruber P P, Kloner R A, Gruentzig A R. Usefulness of intracoronary infusion of fluorocarbon distal to prolonged coronary occlusion by angioplasty balloons in dogs. Am J. Cardiol 1986; 57: 1202–1205
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie F D, Osmialowski A, Zimmerman P, Mergner W, Forman M B. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion. Am Heart J 1988; 116: 421–431
   PubMed Web of Science ®Google Scholar
• Anderson H V, Leimgruber P P, Roubin G S, Nelson D L, Gruentzig A R. Distal coronary artery perfusion during percutaneous transluminal coronary angioplasty. Am Heart J 1985; 110: 720–726
   PubMed Web of Science ®Google Scholar
• Cleman M, Jaffe C C, Wohlgelernter D. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%. Circulation 1986; 74: 555–562
   PubMed Web of Science ®Google Scholar
• Jaffe C C, Wohlgelernter D, Cabin H, Bowman L, Deckelbaum L, Remetz M, Cleman M. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%. Am Heart J 1988; 115: 1156–1164
   PubMed Web of Science ®Google Scholar
• Kent K M, Cleman M W, Cowley M J, Forman M B, Jaffe C C, Kaplan M, King S B, Krucoff M, Lassar T, McAuley B, Smith R, Wisdom C, Wohlgelernter D. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated fluosol. Am J. Cardiol 1990; 66: 279–284
   PubMed Web of Science ®Google Scholar
• Glogar D H, Kloner R A, Muller J, DeBoer Lwv, Braunwald E. Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science 1981; 211: 1439–1441
   PubMed Web of Science ®Google Scholar
• Nunn G R, Dance G, Peters J, Cohn L H. Effect of fluorocarbon exchange transfusion on myocardial infarction size in dogs. Am J. Cardiol 1983; 52: 203–205
   PubMed Web of Science ®Google Scholar
• Biro G P. Effect of hemodilution with dextran, stroma-free hemoglobin solution and fluosol - DA on experimental myocardial ischemia in the dog. Biblthca haemat. No 1981; 47: 54–69
   Google Scholar
• Kolodgie F D, Dawson AK, Forman M B, Virmani R. Effect of perfluorochemical (Fluosol-DA) on infarct morphology in dogs. Virchows Arch [Cell Pathol] 1985; 50: 119–134
   Google Scholar
• Kolodgie F D, Dawson A K, Roden D M, Forman M B, Virmani R. Effect of Fluosol-DA on infarct morphology and vulnerability to ventricular arrhythmia. Am. Heart J 1986; 1192–1200
   PubMedGoogle Scholar
• Faithfull N S, Erdman W, Fennema M. Effects of hemodilution with fluorocarbons or dextran on oxygen tensions in acutely ischemic myocardium. Br. J. Anaesth 1986; 58: 1031–1040
   PubMed Web of Science ®Google Scholar
• Forman M B, Bingham S, Kopelman H, Wehr C, Sandler M P, Kolodgie F, Vaughn W K, Friesinger G C, Virmani R. Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circ 1985; 71: 1060–1068
   PubMed Web of Science ®Google Scholar
• Virmani R, Warren D, Rees R, Fink L M, English D. Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion 1983; 23: 512–525
   PubMed Web of Science ®Google Scholar
• Virmani R, Fink L M, Gunter K, English D. Effect of perfluorochemical blood substitutes on human neutrophil function. Transfusion 1984; 24: 343–347
   PubMedGoogle Scholar
• Menasche P, Escorsin M, Birkui P, Lavergne A, Fauchet M, Commin P, Lorente P, Geyer R P, Piwnica A. Limitations of fluorocarbons in reducing myocardial infarct size. Am J. Cardiol 1985; 55: 830–834
   PubMed Web of Science ®Google Scholar
• Forman M B, Puett D W, Wilson B H, Vaughn W K, Friesinger G C, Virmani R. Beneficial long-term effect of intracoronary perfluorochemical on infarct size and ventricular function in a canine reperfusion model. J. Am Coll Cardiol 1987; 9: 1082–1090
   PubMed Web of Science ®Google Scholar
• Forman M B, Puett D W, Bingham S E, Virmani R, Tantengco M V, Light R T, Bajaj A, Price R, Friesinger G. Preservation of endothelial cell structure and function by intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 1987; 76: 469–479
   PubMedGoogle Scholar
• Forman M B, Puett D W, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: Pathogenesis and Therapeutic Implications. J. Am. Coll Cardiol 1989; 13: 450–459
   PubMed Web of Science ®Google Scholar
• Bajaj A K, Cobb M A, Virmani R, Gay J C, Light R T, Forman M B. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation. Circulation 1989; 79: 645–656
   PubMed Web of Science ®Google Scholar
• Babbitt D G, Forman M B, Jones R, Bajaj A K, Hoover R L. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical. Am J. Pathol 1990; 136: 451–459
   PubMed Web of Science ®Google Scholar
• Kolodgie F D, Virmani R, Farb A, Hart C L. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%). J. Am. Coll. Card 1991; 18: 215–223
   PubMedGoogle Scholar
• Forman M B, Pitarys C J, Vildibill H, Lambert T L, Ingram D A, Virmani R, Murray J J. Pharmacologic perturbation of neutrophils by fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. J. Am. Coll. Cardiol 1992; 19: 205–216
   PubMed Web of Science ®Google Scholar
• Kloner R A, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation 1989; 80: 1115–1127
   PubMed Web of Science ®Google Scholar
• Schaer G L, Karas S P, Santoian E C, Gold C, Visner M C, Virmani R. Reduction in reperfusion injury by blood free reperfusion after experimental myocardial infarction. J. Am. Coll. Cardiol 1990; 15: 1385–1393
   PubMedGoogle Scholar
• Rice H E, Virmani R, Hart C L, Kolodgie F D, Farb A. Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol - DA. Am. Heart J 1990; 120: 1039–1046
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie F D, Osmialowski A F, Forman M B. The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit. Am J. Cardiovasc. Pathol 1990; 3: 69–80
   PubMedGoogle Scholar
• Schaer G L, Hursey T L, Rodriguez R, Campbell D R, Song J K, Monabat N C, Thota V, Parrillo J E. Poloxamer 188, a component of perfluorochemical emulsion (Fluosol) reduces myocardial infarct size in dogs. Circulation 1991; 84: II–619, (Suppl II) (Abstract)
   Google Scholar
• Schaer G L, Hursey T L, Rodriguez R, Tifler E A, Ennis B M, Thota V, Monabat N C, Parrillo J E. Polaxamer 188, a hemorheologic agent, reduces experimental myocardial infarct size: importance for prolonged therapy for reperfusion injury. J. Am Coll. Cardiol 1992; 19: 334A
   Google Scholar
• Forman M B, Ingram D A, Murray J J. Attenuation of myocardial reperfusion injury by perfluorochemical emulsions. Clinical Hemorheology 1992; 12: 121–140
   Google Scholar
• Forman M B, Perry J M, Wilson B H, Verrani M S, Kaplan P R, Shawl F A, Friesinger G C. Demonstration of myocardial reperfusion injury in humans: Results of a pilot study utilizing coronary angioplasty with perfluorochemical in anterior myocardial infarction. J. Am Coll. Cardiol 1991; 18: 911–918
   PubMed Web of Science ®Google Scholar
• Wall T C, Topol E J, Califf R M, Blankenship J, Talley D, Tannenbaum M, Gacioch G, Cohen M, Sanz M, Leimberger J. TAMI 9: Preliminary report of a prospective randomized trial of intravenous fluosol in acute myocardial infarction. Circulation 1992; 86: I–642, (Suppl I)
   Google Scholar
• Cowley M J, Snow F R, DiSciascio G, Kelly K, Guard C, Nixon J V. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients. Circulation 1990; 81: IV-27–IV-34, (Suppl IV)
   Google Scholar